Drs. Nate Pennell, Mary Pinder, and Jack West discuss an
encouraging study of dabrafenib, a BRAF inhibitor, for the limited
number of NSCLC patients with a BRAF V600E mutation.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.